# Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism

> **NCT00565916** · NA · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 22 (actual)

## Conditions studied

- Postmenopausal Syndrome

## Interventions

- **DRUG:** Estrogen
- **DRUG:** Progesterone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00565916
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-08
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Atypically high dropout rate.
- **Last updated:** 2018-10-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00565916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00565916, "Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00565916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*